United States · Funded startup

Who invested in Enalare Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2025, from 1 source

Latest round
Grant, $2.5MJan 2025
Investors
1
See who backed them

The rounds

  1. Jan 2025
    Grant$2.5M

    Source recorded

Founders and team

From the SEC filings it signed: 3 on the team.

  • Daniel MottoExecutive Officeri
  • Herman CukierExecutive Officer, Directori
  • Joseph PergolizziExecutive Officer, Directori

On the board, as filediGino SantiniJoseph PetkoMark ColemanRobert Yedid

Everyone who backed them

NJEDAVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Enalare Therapeutics

Who invested in Enalare Therapeutics?

Enalare Therapeutics's investors include NJEDA.

How much has Enalare Therapeutics raised?

Enalare Therapeutics has raised $2.5M across 1 round since 2025.

When did Enalare Therapeutics last raise?

Enalare Therapeutics's most recent round was a Grant of $2.5M in Jan 2025.

What was Enalare Therapeutics's biggest round?

Its most recent round, $2.5M in Jan 2025, is also its largest on record.

Who backed Enalare Therapeutics first?

Enalare Therapeutics's first round on record, in Jan 2025, was backed by NJEDA.

What stage is Enalare Therapeutics at?

Enalare Therapeutics's latest named round is a Grant, in Jan 2025.

Where is Enalare Therapeutics based?

Enalare Therapeutics is based in the United States.

Companies like Enalare Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.